Williams K A, Morris P J
Clin Exp Immunol. 1977 Feb;27(2):191-7.
Pretransplant sera from thirty-two patients who had received cadaveric renal transplants were screened retrospectively for lymphocyte-dependent antibody (LDA). An 18-hr 51Cr-release assay, using neat serum and an effector: target ratio of 10:1 was employed, each serum being screened against 10 normal target cells. Ten per cent of all reactions tested were positive, compared with 2% when ten normal sera were screened in the same way. No relationship between the presence of LDA pregraft, and the subsequent course of the renal allograft, was apparent in the group as a whole. Patients who had received blood transfusions and who developed LDA before transplantation, had marginally worse graft courses than transfused patients who did not develop LDA, but the difference was not significant. Eight male patients who had never been transfused, nevertheless were found to have LDA. Twelve patients were screened postoperatively for LDA, but only five out of 433 sera tested were positive. It appears that pregraft LDA do not influence the course of a subsequent renal transplant, nor does the appearance of LDA after transplantation allow prediction of acute rejection episodes,
对32例接受尸体肾移植患者的移植前血清进行回顾性淋巴细胞依赖性抗体(LDA)筛查。采用18小时51Cr释放试验,使用纯血清,效应细胞与靶细胞比例为10:1,每种血清针对10个正常靶细胞进行筛查。所有检测反应中有10%呈阳性,而以同样方式筛查10份正常血清时阳性率为2%。总体来看,移植前LDA的存在与肾移植的后续病程之间没有明显关系。接受输血且移植前出现LDA的患者,其移植肾病程略差于未出现LDA的输血患者,但差异不显著。8例从未接受过输血的男性患者被发现有LDA。术后对12例患者进行LDA筛查,但433份检测血清中只有5份呈阳性。看来移植前LDA不影响后续肾移植的病程,移植后LDA的出现也无法预测急性排斥反应发作。